Results 61 to 70 of about 1,701 (232)

cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels

open access: yesBiomolecules, 2023
Chronic infection with hepatitis B virus (HBV) is incurable, as the current therapeutics cannot eliminate its persistent genomic material, cccDNA. Screening systems for cccDNA-targeting therapeutics are unavailable, as low copies of cccDNA in vitro ...
Ee Chee Ren   +5 more
doaj   +1 more source

pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy [PDF]

open access: yes, 2022
Narcolepsy is a debilitating sleep disorder that presents with excessive daytime sleepiness (EDS) and cataplexy, which is a sudden paralysis of muscle tone triggered by strong emotions such as laughing.
Alvarez, Mark   +7 more
core   +1 more source

Development of a conformational histamine H(3) receptor biosensor for the synchronous screening of agonists and inverse agonists [PDF]

open access: yes, 2020
The histamine H(3) receptor (H(3)R) represents a highly attractive drug target for the treatment of various central nervous system disorders, but the discovery of novel H(3)R targeting compounds relies on the assessment of highly amplified intracellular ...
Leurs, R.   +7 more
core   +2 more sources

Substituted Purines as High-Affinity Histamine H3 Receptor Ligands

open access: yesPharmaceuticals, 2022
Continuing with our program to obtain new histamine H3 receptor (H3R) ligands, in this work we present the synthesis, H3R affinity and in silico studies of a series of eight new synthetically accessible purine derivatives.
Christian Espinosa-Bustos   +7 more
doaj   +1 more source

Prader Willi locus Snord116 RNA regulates hypothalamic functions: sleep and temperature [PDF]

open access: yes, 2020
Sleep is a complex behavior and it is hierarchically regulated involving several brain regions, neurotransmitters, and genes that co-operate in building modulatory mechanisms aimed at controlling and maintaining sleep.
FALAPPA, MATTEO
core   +1 more source

Przekaźnictwo histaminergiczne w narkolepsji typu 1 – implikacje terapeutyczne

open access: yesAktualności Neurologiczne, 2018
Narkolepsja typu 1 (narkolepsja z katapleksją) jest chorobą objawiającą się nadmierną sennością dzienną, niekontrolowanym zasypianiem, epizodami katapleksji (nagłej utraty napięcia mięśniowego), halucynacjami hipnagogicznymi i hipnopompicznymi oraz ...
Mariusz Siemiński
doaj   +1 more source

Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility

open access: yesNature and Science of Sleep, 2020
Jay T Guevarra, Robert Hiensch, Andrew W Varga, David M Rapoport Division of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai Integrative Sleep Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USACorrespondence: Jay T ...
Guevarra JT   +3 more
doaj  

Sleep Disorders in Adults with Prader-Willi Syndrome: Review of the Literature and Clinical Recommendations Based on the Experience of the French Reference Centre [PDF]

open access: yes, 2022
Prader–Willi syndrome (PWS) is a rare, genetic, multisymptomatic, neurodevelopmental disease commonly associated with sleep alterations, including sleep-disordered breathing and central disorders of hypersomnolence.
Alice Bellicha   +7 more
core   +1 more source

Auxological and endocrine findings in narcolepsy type 1: seventeen-year follow-up from a pediatric endocrinology center [PDF]

open access: yes, 2023
Introduction: Narcolepsy Type 1 (NT1) is a rare hypersomnia of central origin linked to hypocretin deficiency, most frequently arising at pediatric age. NT1 could be associated with endocrine comorbidities involving the neuroendocrine axis, predominantly
Assirelli V.   +7 more
core   +1 more source

Anti‐Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea

open access: yesChronic Diseases and Translational Medicine, EarlyView.
Cellular and molecular mechanisms of obesity‐related obstructive sleep apnea (OSA). ADMA: asymmetric dimethyrarginine, NLRP3: nucleotide‐binding domain, leucine‐rich repeat family, Pyrin domain containing 3, TLR: toll‐like receptors, IL‐1β: interleukin‐1β, IL‐6: interleukin‐6; LPS: lipopolysacharide, ROS: reactive oxygen species, TNF‐α.
Anish Preshy   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy